(2S,3S)-1-METHYL-N-(2-(4-(4-((4-(((1R,2S,5R)-5-(METHYL(PROPAN-2-YL)AMINO)-2-((3S)-2-OXO-3-((6-(TRIFLUOROMETHYL)QUINAZOLIN-4-YL)AMINO)PYRROLIDIN-1-YL)CYCLOHEXYL)CARBAMOYL)CYCLOHEXYL)AMINO)-4-OXOBUTOXY)CYCLOHEXYL)OXYETHYL)-5-OXO-2-PYRIDIN-3-YLPYRROLIDINE-3-CARBOXAMIDE
UNII U9LG9HZ9QS
Substance Identification & Data
This profile provides standardized clinical and technical data for (2s,3s)-1-methyl-n-(2-(4-(4-((4-(((1r,2s,5r)-5-(methyl(propan-2-yl)amino)-2-((3s)-2-oxo-3-((6-(trifluoromethyl)quinazolin-4-yl)amino)pyrrolidin-1-yl)cyclohexyl)carbamoyl)cyclohexyl)amino)-4-oxobutoxy)cyclohexyl)oxyethyl)-5-oxo-2-pyridin-3-ylpyrrolidine-3-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U9LG9HZ9QS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2904546-77-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C53H73F3N10O7 IUEFGOGKSBGEJR-ZWRQJOCDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2s,3s)-1-methyl-n-(2-(4-(4-((4-(((1r,2s,5r)-5-(methyl(propan-2-yl)amino)-2-((3s)-2-oxo-3-((6-(trifluoromethyl)quinazolin-4-yl)amino)pyrrolidin-1-yl)cyclohexyl)carbamoyl)cyclohexyl)amino)-4-oxobutoxy)cyclohexyl)oxyethyl)-5-oxo-2-pyridin-3-ylpyrrolidine-3-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.